Biogened Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Biogened heeft een totaal eigen vermogen van PLN39.3M en een totale schuld van PLN23.3M, wat de schuld-eigenvermogensverhouding op 59.2% brengt. De totale activa en totale passiva bedragen respectievelijk PLN87.0M en PLN47.7M. De EBIT Biogened is PLN8.4M waardoor de rentedekking 3.7 is. Het heeft contanten en kortetermijnbeleggingen van PLN6.2M.

Belangrijke informatie

59.2%

Verhouding schuld/eigen vermogen

zł23.29m

Schuld

Rente dekkingsratio3.7x
Contantzł6.16m
Aandelenzł39.32m
Totaal verplichtingenzł47.66m
Totaal activazł86.97m

Recente financiële gezondheidsupdates

Recent updates

Biogened (WSE:BGD) Takes On Some Risk With Its Use Of Debt

Nov 06
Biogened (WSE:BGD) Takes On Some Risk With Its Use Of Debt

A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Aug 28
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Aug 22
Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

May 23
Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

May 09
Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Feb 21
Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Is Biogened (WSE:BGD) A Risky Investment?

Feb 01
Is Biogened (WSE:BGD) A Risky Investment?

Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

Feb 01
Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Jun 30
We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Oct 08
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jun 29
Is Biogened (WSE:BGD) A Risky Investment?

Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

Mar 25
Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Jul 29
Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Apr 30
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jan 24
Is Biogened (WSE:BGD) A Risky Investment?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( PLN52.7M ) BGD } overtreffen de korte termijn passiva ( PLN23.4M ).

Langlopende schulden: De kortetermijnactiva BGD ( PLN52.7M ) overtreffen de langetermijnschulden ( PLN24.2M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 43.6% ) BGD wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van BGD is de afgelopen 5 jaar gestegen van 40.6% naar 59.2%.

Schuldendekking: De schuld van BGD wordt goed gedekt door de operationele kasstroom ( 20.1% ).

Rentedekking: De rentebetalingen op de schuld van BGD worden goed gedekt door EBIT ( 3.7 x dekking).


Balans


Ontdek gezonde bedrijven